Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Recommendations for diagnosis and management of multiple sclerosis.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Functional role of TRP channels in modulating ER stress and Autophagy.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Seeing optic neuritis through myopic eyes.
Time to see the light.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Multiple sclerosis: An old drug plays a new trick.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Physiotherapy as an immunoactive therapy? A pilot study.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Placebo power.

Pages